Stem cell trial's upbeat interim findings

January 8, 2018

Stem cell trial's upbeat interim findings

Download video (broadcast and web versions) of Drs. Martin Childers and David Mack, researchers at the University of Washington School of Medicine, discussing favorable interim results from the first patients treated for X-linked myotubular myopathy, a rare muscle-wasting disease that affects young boys.  Their research at the UW Institute for Stem Cell and Regenerative Medicine showed that the therapy successfully treated dogs with a form of muscular dystrophy. That same therapy is now being tested in the clinical trial of patients.

Childers discusses the topic in this downloadable video segment. 

Tags: 
gene therapy
muscular dystrophy
MediaAMP
Download Asset Page: 
Download video assets of Drs. Childers and Mack describing their work and the clinical trial's interim results.

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images and stock video from Getty Images, but we cannot grant republishing rights. You may not republish single image files, videos or animations credited to Getty Images.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or mediarelations@uw.edu